Biosimilars and Interchangeable Biologics: Tactical Elements - Image 1

£171.39

CRC Press Biosimilars and Interchangeable Biologics: Tactical Elements

Name: Biosimilars and Interchangeable Biologics: Tactical Elements
Brand: CRC Press
Price: 171.39 GBP
Availability: InStock

Pharmacy - Dispensing

It has never been this cheap. We have no record of a lower price.

£171 today · cheaper than every other day in the last 4 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 16 days • 16 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 16 days • 1 price levels

Days at Price

Price Analysis

Most common price: £171 (16 days, 100.0%)

Price range: £171 - £171

Price levels: 1 different prices over 16 days

Description

What’s the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars and Interchangeable Biologics: Tactical Elements explores the development and manufacturing of biosimilars and targets challenges surrounding the creation of these products. This includes manufacturing, production costs, and intellectual property barriers, particularly in regulated markets (regulatory agencies are still in the process of developing guidelines). It addresses the complexity of biological drugs, and it discusses specific structural elements vital to the functionality, immunogenicity, and safety of biosimilar products. Of specific interest to practitioners, researchers, and scientists in the biopharmaceutical industry, this volume provides an overall understanding of the hurdles, difficulties, and practicalities of developing a strong plan. It introduces a step-by-step approach for creating a strategy that helps develop and manufacture a biosimilar product while reducing overall production costs and meeting the requirements of biosimilarity based on analytical and functional, pharmacokinetic, pharmacodynamic (where applicable), and nonclinical toxicology or toxicokinetic similarity (where appropriate) while remaining competitive in the market.

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 1498743498
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 27 January 2016
Listed Since: 04 May 2015

Barcode

No barcode data available

CRC Press Biosimilars and Interchangeable Biologics: Tactical Elements

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilars Development Strategies: Fast to Market Approaches

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Biosimilars: A New Generation of Biologics

Biosimilars: A New Generation of Biologics

Biosimilar Drug Product Development (Drugs and the Pharmaceutical Sciences)

Biosimilars and Interchangeable Biologics: Strategic Elements

ASHP Biosimilars and Biologics - Implementation and Monitoring

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Digital Therapeutics: Strategic, Scientific, Developmental, and Regulatory Aspects (Chapman & Hall/CRC Biostatistics Series)

PHARMACEUTICAL ECONOMICS AND POLICY 3RD EDITION: Perspectives, Promises, and Problems

Biopharmaceuticals: Challenges and Opportunities

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

A Biotech Manager's Handbook: A Practical Guide (Woodhead Publishing Series in Biomedicine)

Commercialization of BioPharma Products in the USA (BW): A Practical Guide

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

Medical Writing in Drug Development: A Practical Guide for Pharmaceutical Research

The 2023-2028 Outlook for Bioengineered Monoclonal Antibodies Protein Drugs in Japan